WEKO3
アイテム
{"_buckets": {"deposit": "38c1ec51-c3cc-4c99-b4f6-15ef5b2ce237"}, "_deposit": {"created_by": 5, "id": "2969", "owners": [5], "pid": {"revision_id": 0, "type": "depid", "value": "2969"}, "status": "published"}, "_oai": {"id": "oai:yamanashi.repo.nii.ac.jp:00002969", "sets": ["259"]}, "author_link": ["13694", "13695", "13696", "13697", "13698", "13699"], "item_10001_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2001", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "24", "bibliographicPageStart": "15", "bibliographicVolumeNumber": "16", "bibliographic_titles": [{"bibliographic_title": "山梨医科大学雑誌", "bibliographic_titleLang": "ja"}, {"bibliographic_title": "Yamanashi medical journal", "bibliographic_titleLang": "en"}]}]}, "item_10001_creator_2": {"attribute_name": "著者名", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Shimoda, Hiromichi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "13694", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tawata, Masato", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "13695", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Umetani, Ken", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "13696", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shindo, Hideo", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "13697", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Aida, Kaoru", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "13698", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Onaya, Toshimasa", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "13699", "nameIdentifierScheme": "WEKO"}]}]}, "item_10001_description_5": {"attribute_name": "内容", "attribute_value_mlt": [{"subitem_description": "The effect of lipo-prostaglandin E1 on heart rate variability (HRV) was investigated in 30 hospitalized patients with type 2 diabetes mellitus. After evaluating HRV, patients were divided into Control and Treatment groups. The Control group received the continuation of glycemic control, while the Treatment group received an infusion of 10 mg lipo-prostaglandin E1/day for seven days in addition to glycemic control. HRV was re-evaluated seven days after the first examination in both groups. The parameters are ; 1) time domain indices consisting of standard deviation of all normal R-R intervals, standard deviation of the means of all 5-min segments of normal R-R intervals, mean of the standard deviation of all normal R-R intervals for all 5-min segments ; 2) frequency domain indices consisting of very low frequency power, low frequency power, high frequency power and total frequency power. There was no significant change in HRV indices between the two examinations in the Control group, whereas there was a significant increase in seven HRV indices between the two examinations in the Treatment group. The present study suggests that lipo-prostaglandin E1 improves autonomic function in patients with type 2 diabetes mellitus.", "subitem_description_language": "en", "subitem_description_type": "Other"}]}, "item_10001_identifier_registration": {"attribute_name": "ID登録", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.34429/00002962", "subitem_identifier_reg_type": "JaLC"}]}, "item_10001_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "山梨医科大学医学会", "subitem_publisher_language": "ja"}]}, "item_10001_source_id_11": {"attribute_name": "NCID", "attribute_value_mlt": [{"subitem_source_identifier": "AN10044054", "subitem_source_identifier_type": "NCID"}]}, "item_10001_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0912-0025", "subitem_source_identifier_type": "ISSN"}]}, "item_10001_version_type_20": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-02-27"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "AN10044054_16_01_03.pdf", "filesize": [{"value": "82.1 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_note", "mimetype": "application/pdf", "size": 82100.0, "url": {"label": "AN10044054_16_01_03.pdf", "objectType": "fulltext", "url": "https://yamanashi.repo.nii.ac.jp/record/2969/files/AN10044054_16_01_03.pdf"}, "version_id": "e257ea8c-aec3-439d-be72-459d7c85005a"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Diabetic autonomic neuropathy", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Lipo-prostaglandin E1", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Heart rate variability", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Time and spectral analyses", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Parasympathetic activity", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "\u003cOriginal Article\u003eLipo-Prostaglandin E1 Improves Heart Rate Variability in Patients with Type 2 Diabetes Mellitus", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "\u003cOriginal Article\u003eLipo-Prostaglandin E1 Improves Heart Rate Variability in Patients with Type 2 Diabetes Mellitus", "subitem_title_language": "en"}]}, "item_type_id": "10001", "owner": "5", "path": ["259"], "permalink_uri": "https://doi.org/10.34429/00002962", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2010-05-18"}, "publish_date": "2010-05-18", "publish_status": "0", "recid": "2969", "relation": {}, "relation_version_is_last": true, "title": ["\u003cOriginal Article\u003eLipo-Prostaglandin E1 Improves Heart Rate Variability in Patients with Type 2 Diabetes Mellitus"], "weko_shared_id": -1}
<Original Article>Lipo-Prostaglandin E1 Improves Heart Rate Variability in Patients with Type 2 Diabetes Mellitus
https://doi.org/10.34429/00002962
https://doi.org/10.34429/0000296221b46ede-95ba-4580-9ecb-6a8f78407161
名前 / ファイル | ライセンス | アクション |
---|---|---|
AN10044054_16_01_03.pdf (82.1 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-05-18 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | <Original Article>Lipo-Prostaglandin E1 Improves Heart Rate Variability in Patients with Type 2 Diabetes Mellitus | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
言語 | en | |||||
主題 | Diabetic autonomic neuropathy | |||||
キーワード | ||||||
言語 | en | |||||
主題 | Lipo-prostaglandin E1 | |||||
キーワード | ||||||
言語 | en | |||||
主題 | Heart rate variability | |||||
キーワード | ||||||
言語 | en | |||||
主題 | Time and spectral analyses | |||||
キーワード | ||||||
言語 | en | |||||
主題 | Parasympathetic activity | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
ID登録 | ||||||
ID登録 | 10.34429/00002962 | |||||
ID登録タイプ | JaLC | |||||
著者名 |
Shimoda, Hiromichi
× Shimoda, Hiromichi× Tawata, Masato× Umetani, Ken× Shindo, Hideo× Aida, Kaoru× Onaya, Toshimasa |
|||||
内容 | ||||||
内容記述タイプ | Other | |||||
内容記述 | The effect of lipo-prostaglandin E1 on heart rate variability (HRV) was investigated in 30 hospitalized patients with type 2 diabetes mellitus. After evaluating HRV, patients were divided into Control and Treatment groups. The Control group received the continuation of glycemic control, while the Treatment group received an infusion of 10 mg lipo-prostaglandin E1/day for seven days in addition to glycemic control. HRV was re-evaluated seven days after the first examination in both groups. The parameters are ; 1) time domain indices consisting of standard deviation of all normal R-R intervals, standard deviation of the means of all 5-min segments of normal R-R intervals, mean of the standard deviation of all normal R-R intervals for all 5-min segments ; 2) frequency domain indices consisting of very low frequency power, low frequency power, high frequency power and total frequency power. There was no significant change in HRV indices between the two examinations in the Control group, whereas there was a significant increase in seven HRV indices between the two examinations in the Treatment group. The present study suggests that lipo-prostaglandin E1 improves autonomic function in patients with type 2 diabetes mellitus. | |||||
言語 | en | |||||
出版者 | ||||||
言語 | ja | |||||
出版者 | 山梨医科大学医学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0912-0025 | |||||
NCID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN10044054 | |||||
書誌情報 |
ja : 山梨医科大学雑誌 en : Yamanashi medical journal 巻 16, 号 1, p. 15-24, 発行日 2001 |
|||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 |